Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Q.G.C.M. van Hoesel"'
Autor:
Sjoerd Rodenhuis, Nanno Mulder, W.T.A. van der Graaf, E. van der Wall, E.G.E. de Vries, W.M. Smit, M. Nooij, Pierre S. Hupperets, M. Bontenbal, Q.G.C.M. van Hoesel, Patrick Nieboer, Emile E. Voest, Hendrika Boezen
Publikováno v:
Bone Marrow Transplantation, 42(7), 475-481. Nature Publishing Group
Bone marrow transplantation, 42(7), 475-481. Nature Publishing Group
Bone Marrow Transplantation, 42, 475-81
Nieboer, P, de Vries, E G E, Mulder, N H, Rodenhuis, S, Bontenbal, M, van der Wall, E, van Hoesel, Q G, Smit, W M, Hupperets, P, Voest, E E, Nooij, M A, Boezen, H M & van der Graaf, W T A 2008, ' Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients ', Bone Marrow Transplantation, vol. 42, no. 7, pp. 475-481 . https://doi.org/10.1038/bmt.2008.195
Bone Marrow Transplantation, 42, 7, pp. 475-81
Bone marrow transplantation, 42(7), 475-481. Nature Publishing Group
Bone Marrow Transplantation, 42, 475-81
Nieboer, P, de Vries, E G E, Mulder, N H, Rodenhuis, S, Bontenbal, M, van der Wall, E, van Hoesel, Q G, Smit, W M, Hupperets, P, Voest, E E, Nooij, M A, Boezen, H M & van der Graaf, W T A 2008, ' Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients ', Bone Marrow Transplantation, vol. 42, no. 7, pp. 475-481 . https://doi.org/10.1038/bmt.2008.195
Bone Marrow Transplantation, 42, 7, pp. 475-81
Item does not contain fulltext Neutropenia following high-dose chemotherapy leads to a high incidence of infectious complications, of which central venous catheter-related infections predominate. Catheter-related infections and associated risk factor
Autor:
Jean-Paul Guastalla, Jan B. Vermorken, Sergio Pecorelli, A. J. Lacave, G. Hoctin-Boes, V. Scotto di Palumbo, M.A. Nooij, Catherine Lhommé, Giorgio Bolis, Q.G.C.M. van Hoesel, Nicoletta Colombo, H.C. Wagenaar, Andrés Cervantes, Ignace Vergote, Andres Poveda, G. Zanetta, M. Namer
Publikováno v:
Gynecologic oncology
Objectives. To investigate tumor response rate and treatment toxicity of a modified combination chemotherapy consisting of bleomycin (B), methotrexate (M), and CCNU (C) for patients with locally advanced, squamous-cell carcinoma of the vulva (not ame
Autor:
John Radford, Jean-Yves Blay, Claus Kamby, A. van Oosterom, Q.G.C.M. van Hoesel, E. Donato Di Paola, Cédric Hermans, S Nielsen, A. Le Cesne, Jaap Verweij, Maggie A Harris, Mark Clemons, J Whittaker, Ian Judson
Publikováno v:
European Journal of Cancer. 37:870-877
CAELYX/DOXIL, pegylated liposomal doxorubicin, has shown antitumour activity and reduced toxicity compared with standard doxorubicin in other tumour types. In this prospective randomised trial, 94 eligible patients with advanced soft-tissue sarcoma (
Autor:
Q.G.C.M. van Hoesel, Pilar Lianes, C. Debruyne, Desmond Curran, G. Giaccone, G.V. Scagliotti, Tarek Sahmoud, M.C. Pennucci, N. van Zandwijk, Ted A.W. Splinter, Pe Postmus, J. Van Meerbeeck, G. S. Kho
Publikováno v:
Journal of Clinical Oncology. 16:2133-2141
PURPOSE To compare two cisplatin based chemotherapy schedules in patients with advanced non-small-cell lung cancer (NSCLC). PATIENTS AND METHODS A total of 332 patients with advanced NSCLC were randomized to receive cisplatin 80 mg/m2 on day 1 either
Publikováno v:
Critical Reviews in Oncology Hematology, 21, 77-103
Critical Reviews in Oncology Hematology, 21, pp. 77-103
Critical Reviews in Oncology Hematology, 21, pp. 77-103
Contains fulltext : 155579.pdf (Publisher’s version ) (Open Access)
Autor:
Joseph Kerger, Henning T. Mouridsen, Thomas Tursz, Jaap Verweij, M. Clavel, G. Catimel, A. van Oosterom, M. van Glabbeke, N Le Bail, Q.G.C.M. van Hoesel, C. van Pottelsberghe, P. Kerbrat
Publikováno v:
Annals of Oncology. 5:539-542
Summary Background Current regimens for treatment of distant metastases of soft tissue sarcomas result in response rates of about 25%. Therefore the search for active drugs remains a task for investigationaJ groups. Taxoids offer a new class of cytos
Autor:
David M. Burger, C.M.L. van Herpen, Q.G.C.M. van Hoesel, Jos H. Beijnen, Ingrid M.E. Desar, W.T.A. van der Graaf
Publikováno v:
Annals of Oncology, 20, 3, pp. 599-600
Annals of Oncology, 20, 599-600
Annals of Oncology, 20, 599-600
Contains fulltext : 79495.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec8b564ed5473f4c83b2915882aec54f
https://doi.org/10.1093/annonc/mdn779
https://doi.org/10.1093/annonc/mdn779
Autor:
D.J.A. Crommelin, U. K. Nässander, Wijnand Eling, W. H. de Jong, Gert Storm, J. Zuidema, Q.G.C.M. van Hoesel, P. A. Steerenberg
Publikováno v:
Journal of Controlled Release. 16:147-154
The potential of liposomes for the intramuscular (i.m.) or subcutaneous (s.c.) delivery of drugs is discussed. Protection against a malaria infection after an i.m. or s.c. injection of chloroquine (CQ) containing liposomes was studied in mice. At pre
Autor:
Emile E. Voest, E. van der Wall, M. Bontenbal, W.M. Smit, M. Nooij, Petra Kristel, de Elisabeth G. E. Vries, M.J. van de Vijver, Sjoerd Rodenhuis, H. van Tinteren, P. Hupperets, Q.G.C.M. van Hoesel, Juliane Hannemann
Publikováno v:
British Jounal of Cancer, 95(10), 1334-1341. Nature Publishing Group
British Journal of Cancer, 95(10), 1334-1341. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 95, 1334. Macmillan Press
British journal of cancer, 95(10), 1334-1341. Nature Publishing Group
British Journal of Cancer, 95(10), 1334-1341. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 95, 1334. Macmillan Press
British journal of cancer, 95(10), 1334-1341. Nature Publishing Group
Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up of the tumour. In a retrospective analysis, we determined the molecular subtypes of breast cancer originally defined by expression microarrays by imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22785aa996dac1dbf09847c0d6adaedb
https://research.rug.nl/en/publications/082ae43e-d702-4b44-bd7f-5ce72666ff8c
https://research.rug.nl/en/publications/082ae43e-d702-4b44-bd7f-5ce72666ff8c
Autor:
M. Bontenbal, H. van Tinteren, Q.G.C.M. van Hoesel, Sjoerd Rodenhuis, M.J. van de Vijver, E. van der Wall, W.M. Smit, M Nooij, Johannes L. Peterse, E. G. E. de Vries, Emile E. Voest, Pierre S. Hupperets
Publikováno v:
Annals of oncology, 17, 588. Oxford University Press
Annals of Oncology, 17(4), 588-596. Elsevier Ltd.
Annals of oncology, 17(4), 588-596. Oxford University Press
Annals of Oncology, 17(4), 588-596. Oxford University Press
Annals of Oncology, 17(4), 588-596. Elsevier Ltd.
Annals of oncology, 17(4), 588-596. Oxford University Press
Annals of Oncology, 17(4), 588-596. Oxford University Press
Background: High-dose chemotherapy in the adjuvant treatment of breast cancer has been abandoned by many.Patients and methods: 885 patients with stage III primary breast cancer and four or more axillary lymph node metastases were randomised to receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e2cba20b01c3481de658b915ecc5ae
https://dspace.library.uu.nl/handle/1874/21775
https://dspace.library.uu.nl/handle/1874/21775